Objectives for Learning

BloodVessel

  • What are the latest guidelines for managing patients with hyperlipidemia
  • What is the latest in hyperlipidemia management in patients with CKD?
  • What is the impact of the SHARP study in patients with CKD
  • What is new on the horizon in lipid management: raising HDL with CETP inhibitors

Our Expert Faculty:

  • Dr. Lawrence Leiter, Endocrinologist (St. Michael's Hospital, University of Toronto)
  • Dr. Phil McFarlane, Nephrologist (St. Michael's Hospital, University of Toronto)
  • Dr. Subodh Verma, Cardiac Surgeon (St. Michael's Hospital, University of Toronto)

Select a presentation

Title2-Title2-Title3-

This program was supported by an unrestricted grant from Merck Canada. Merck Canada was not involved in the content development


ukidneyisup